Critical Early Diagnoses and Acute Exacerbations in IPF and PPF
Paul Noble, MD, discusses the importance of early diagnosis in patients with IPF or PPF.
Video content above is prompted by the following:
- Why is an early diagnosis of IPF and PPF so critical for patients and why is this disease often misdiagnosed?
- How acute exacerbations in IPF and PPF defined and why are they so burdensome for patients diagnosed with the disease?
Recent Videos
Related Content
Value-Based Decision-Making in Metastatic Breast Cancer
September 16th 2021Article
In this Managed Healthcare Executive® KCast, Ian Krop, M.D., Ph.D., oncologist and associate professor of medicine at Dana-Farber Cancer Institute in Boston, and Debra Patt, M.D., Ph.D., MBA, executive vice president at Texas Oncology in Austin, provide key insights into the value-based care model for patients with HER2-positive metastatic breast cancer (mBC). This article summarizes the highlights of the discussion.
Read More
